Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Villareal DT, Banks M, Sinacore DR, Siener C, Klein S
Use of dipeptidyl peptidase-4 inhibitors and risk of bone fracture in patients with type 2 diabetes in Germany-a retrospective analysis of real-world data
Ozempic, although originally used to treat diabetes, is increasingly being prescribed off-label for weight loss
Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, and Morrow JD
Pemvidutide (ALT-801) is another unimolecular once weekly GLP-1/glucagon agonist undergoing a phase 2 trial as obesity treatment, following a phase 1 trial demonstrating up to 10.3% WL at 12 weeks [73]
US$ 28.63
US$ 23.27
US$ 24.93
